ELUT (Elutia) Beginning Cash Position: $36.35 Mil (As of Mar. 2026)


ELUT Elutia Inc ELUT
36 GF Score
Price $0.97
GF Value $0.90
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Elutia Beginning Cash Position?

Elutia ELUT -0.93% 36 Beginning Cash Position is $36.35 Mil as of Mar. 2026. GuruFocus rates ELUT with a GF Score™ of 36/100 and a GF Value™ of $0.90 (Fairly Valued). The stock has 5 warning signs investors should review.

Elutia's Beginning Cash Position for the quarter that ended in Mar. 2026 was $36.35 Mil.

Elutia's quarterly Beginning Cash Position declined from Sep. 2025 ($8.50 Mil) to Dec. 2025 ($4.72 Mil) but then increased from Dec. 2025 ($4.72 Mil) to Mar. 2026 ($36.35 Mil).

Elutia's annual Beginning Cash Position increased from Dec. 2023 ($16.99 Mil) to Dec. 2024 ($19.28 Mil) but then declined from Dec. 2024 ($19.28 Mil) to Dec. 2025 ($13.24 Mil).

Elutia Beginning Cash Position Related Terms

Elutia Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Elutia's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elutia Beginning Cash Position Chart

Elutia Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 39.53 30.43 16.99 19.28 13.24

Elutia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.24 17.36 8.50 4.72 36.35
ELUT
36GF Score
Elutia Inc ELUT
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elutia Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $36.35 Mil mean?
Elutia (ELUT) has a Beginning Cash Position of $36.35 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Elutia and its competitors.
Is Elutia's Beginning Cash Position too high?
Elutia's current Beginning Cash Position is $36.35 Mil. Overall, Elutia has a GF Score™ of 36/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Elutia's Beginning Cash Position compare to NSYS and MYO?
Elutia's Beginning Cash Position of $36.35 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Elutia and its competitors. Elutia's current Beginning Cash Position is $36.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elutia stock overvalued right now?
Based on GuruFocus' analysis, Elutia (ELUT) is currently considered Fairly Valued. The stock's GF Value™ is $0.90, compared to a current price of $0.97 — trading 7.8% above its estimated fair value. The current Beginning Cash Position is $36.35 Mil. Elutia's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Elutia (ELUT), the current Beginning Cash Position is $36.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elutia (ELUT) Overvalued in 2026?

Based on GuruFocus' analysis, Elutia stock appears to be overvalued. The current stock price of $0.97 is trading 7.8% above its estimated GF Value™ of $0.90. GuruFocus considers Elutia to be Fairly Valued.

Key valuation signals for ELUT:

  • Beginning Cash Position: $36.35 Mil
  • GF Value™: $0.90 vs. price of $0.97 (7.8% above fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the ELUT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elutia Business Description

Address 20 Firstfield Road, Gaithersburg, MD, USA, 20878
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
36GF Score

Get the complete analysis for ELUT

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.97
Price
$0.90
GF Value